Mazor Robotics Ltd. (MZOR) Position Boosted by Advisor Group Inc.
Advisor Group Inc. raised its stake in shares of Mazor Robotics Ltd. (NASDAQ:MZOR) by 365.8% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,795 shares of the medical instruments supplier’s stock after buying an additional 2,195 shares during the period. Advisor Group Inc.’s holdings in Mazor Robotics were worth $138,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the business. Dimensional Fund Advisors LP boosted its stake in shares of Mazor Robotics by 8.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 8,570 shares of the medical instruments supplier’s stock valued at $296,000 after buying an additional 641 shares during the period. Royal Bank of Canada boosted its stake in shares of Mazor Robotics by 9.2% during the 2nd quarter. Royal Bank of Canada now owns 21,663 shares of the medical instruments supplier’s stock valued at $749,000 after buying an additional 1,819 shares during the period. Candriam Luxembourg S.C.A. boosted its stake in shares of Mazor Robotics by 1.9% during the 3rd quarter. Candriam Luxembourg S.C.A. now owns 159,052 shares of the medical instruments supplier’s stock valued at $7,852,000 after buying an additional 2,983 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Mazor Robotics during the 2nd quarter valued at $135,000. Finally, Halbert Hargrove Russell LLC acquired a new stake in shares of Mazor Robotics during the 3rd quarter valued at $214,000. 26.46% of the stock is owned by institutional investors.
A number of equities research analysts have issued reports on MZOR shares. Barclays reissued a “hold” rating and set a $34.00 target price on shares of Mazor Robotics in a research note on Wednesday, October 11th. Zacks Investment Research lowered shares of Mazor Robotics from a “hold” rating to a “sell” rating in a research note on Thursday, November 9th. Needham & Company LLC reissued a “hold” rating on shares of Mazor Robotics in a research note on Tuesday, November 7th. Ladenburg Thalmann Financial Services set a $67.00 target price on shares of Mazor Robotics and gave the company a “buy” rating in a research note on Monday, October 30th. Finally, TheStreet raised shares of Mazor Robotics from a “d” rating to a “c-” rating in a research note on Wednesday, November 8th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and one has given a buy rating to the company’s stock. Mazor Robotics has an average rating of “Hold” and an average price target of $39.83.
WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/12/02/mazor-robotics-ltd-mzor-position-boosted-by-advisor-group-inc.html.
Mazor Robotics Company Profile
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Stock Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related stocks with our FREE daily email newsletter.